Literature DB >> 10493952

Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa.

T Okino1, H Egami, H Ohmachi, E Takai, Y Tamori, K Nakagawa, S Nakano, J Akagi, O Sakamoto, T Suda, M Ogawa.   

Abstract

The presence of RON and its variant isoform in malignant and non-malignant human colonic tissues was examined by immunohistochemistry using paraffin-embedded sections and RT-PCR analysis followed by direct sequencing of PCR product using RNAs isolated from frozen tissues. In normal colonic mucosa, RON was uniformly expressed in crypt cells, especially in the bottom of crypta. On the other hand, the expression was distributed heterogeneously in adenomas and in colon cancer. The expression of RON was significantly related to the degree of differentiation of colon cancer and the deletion of the expression was observed in colon cancer specimens with high incidence. The RT-PCR analysis of RNA isolated from non-malignant and malignant colonic tissue revealed the presence of two RON mRNA isoforms with 432-bp and 286-bp. Direct sequencing of major product of 432-bp was revealed to be identical to that of human wild-type RON. On the other hand, major product of 286-bp was revealed to be almost identical to that of a splicing variant of RON transcript which has been found in human gastric cancer cell line, KATO-III. The results obtained in this study may indicate that both wild-type RON and its variant isoform play an important role in regulating the normal function of colonic mucosa such as differentiation and motile activity and the expression of both wild-type RON and its variant isoform could be considered to be reduced during malignancy of human colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493952     DOI: 10.3892/ijo.15.4.709

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma.

Authors:  Marco K C Hui; Kenneth K Y Lai; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  Med Oncol       Date:  2011-11-16       Impact factor: 3.064

Review 2.  Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Authors:  Purnima K Wagh; Belinda E Peace; Susan E Waltz
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

3.  The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice.

Authors:  Sara E Meyer; Susan E Waltz; Kathleen H Goss
Journal:  Mol Carcinog       Date:  2009-11       Impact factor: 4.784

4.  RRM but not the Asp/Glu domain of hnRNP C1/C2 is required for splicing regulation of Ron exon 11 pre-mRNA.

Authors:  Heegyum Moon; Ha Na Jang; Yongchao Liu; Namjeong Choi; Jagyeong Oh; Jiyeon Ha; Hyeon Ho Kim; Xuexiu Zheng; Haihong Shen
Journal:  BMB Rep       Date:  2019-11       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.